semaglutide mash approval glp 1 approved for GLP-1 BREAKTHROUGH: FDA APPROVES TREATMENT SERIOUS LIVER DISEASE Semaglutide, a A New Phase in MASH

GLP-1 aids in regulating insulin, enhances satiety, and supports blood sugar control

adults are taking GLP-1 receptor agonists for chronic disease management or weight loss, they're tied to rare but serious eye complications

In cats, taurine is an essential nutrient

In-Office Care: Miami, Hollywood, Aventura, Coral Springs, and the greater South Florida area

This occurs because semaglutide's appetite-suppressing effects reverse, gastric emptying returns to normal speed, and the metabolic adaptations that occur with weight loss (including reduced energy expenditure) persist

A provider may discuss switching from semaglutide to tirzepatide if progress has slowed, appetite control is not adequate, side effects are manageable and the patients health history supports the change